DK1250125T3 - Farmaceutiske præparater, som indeholder terbinafin - Google Patents

Farmaceutiske præparater, som indeholder terbinafin

Info

Publication number
DK1250125T3
DK1250125T3 DK01925320T DK01925320T DK1250125T3 DK 1250125 T3 DK1250125 T3 DK 1250125T3 DK 01925320 T DK01925320 T DK 01925320T DK 01925320 T DK01925320 T DK 01925320T DK 1250125 T3 DK1250125 T3 DK 1250125T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals containing
containing terbinafine
terbinafine
pharmaceuticals
composition
Prior art date
Application number
DK01925320T
Other languages
Danish (da)
English (en)
Inventor
Jean-Daniel Bonny
Andreas Carl Eugster
Patrice Guitard
Stefan Hirsch
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1250125T3 publication Critical patent/DK1250125T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK01925320T 2000-01-27 2001-01-25 Farmaceutiske præparater, som indeholder terbinafin DK1250125T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0001928.1A GB0001928D0 (en) 2000-01-27 2000-01-27 Organic compounds
PCT/EP2001/000834 WO2001054675A2 (en) 2000-01-27 2001-01-25 Pharmaceutical compositions comprising terbinafine

Publications (1)

Publication Number Publication Date
DK1250125T3 true DK1250125T3 (da) 2004-03-29

Family

ID=9884486

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01925320T DK1250125T3 (da) 2000-01-27 2001-01-25 Farmaceutiske præparater, som indeholder terbinafin

Country Status (12)

Country Link
US (4) US20090143479A1 (de)
EP (1) EP1250125B1 (de)
JP (1) JP5036114B2 (de)
AT (1) ATE255407T1 (de)
AU (1) AU5211901A (de)
DE (1) DE60101370T2 (de)
DK (1) DK1250125T3 (de)
ES (1) ES2211797T3 (de)
GB (1) GB0001928D0 (de)
PT (1) PT1250125E (de)
TR (1) TR200400314T4 (de)
WO (1) WO2001054675A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60231549D1 (de) * 2001-12-03 2009-04-23 Dor Biopharma Inc Stabilisierte umkehr-mizellen-zusammensetzungen und ihre verwendung
JP2005104924A (ja) * 2003-09-30 2005-04-21 Kobayashi Pharmaceut Co Ltd 外用医薬組成物
FR2861992B1 (fr) * 2003-11-10 2007-07-20 Sanofi Synthelabo Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
CN101467960B (zh) * 2007-12-29 2012-11-28 浙江康恩贝制药股份有限公司 一种盐酸特比萘芬乳膏及其制备方法
JO3337B1 (ar) * 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
KR101623928B1 (ko) * 2015-02-24 2016-05-24 한양대학교 에리카산학협력단 자가나노유화 약물 전달시스템을 이용한 에제티미브의 경구용 고형제제 조성물
US12594260B2 (en) * 2024-06-28 2026-04-07 Topical Rx, LLC Topical formulations for infections

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3694557A (en) * 1970-10-23 1972-09-26 Amazon Natural Drug Co The Anti-inflammation compositions containing taspine or acid salts thereof and method of use
JPS5913717A (ja) * 1982-07-16 1984-01-24 Asahi Chem Ind Co Ltd エマルジヨン製剤
EP0295865B1 (de) * 1987-06-15 1994-01-26 Sbp, Inc. Esswaren enthaltend Parenchymzellen-Zellulose
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
JPH10338613A (ja) * 1997-06-06 1998-12-22 Pola Chem Ind Inc 透明化粧料
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
CN1208047C (zh) * 1997-07-29 2005-06-29 法玛西雅厄普约翰美国公司 亲脂性化合物的自体乳化剂
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions

Also Published As

Publication number Publication date
JP5036114B2 (ja) 2012-09-26
EP1250125A2 (de) 2002-10-23
AU5211901A (en) 2001-08-07
ES2211797T3 (es) 2004-07-16
WO2001054675A2 (en) 2001-08-02
DE60101370T2 (de) 2004-10-28
US20090143479A1 (en) 2009-06-04
EP1250125B1 (de) 2003-12-03
US20110086071A1 (en) 2011-04-14
US20130236514A1 (en) 2013-09-12
TR200400314T4 (tr) 2004-03-22
DE60101370D1 (de) 2004-01-15
ATE255407T1 (de) 2003-12-15
JP2003521495A (ja) 2003-07-15
GB0001928D0 (en) 2000-03-22
PT1250125E (pt) 2004-04-30
US20120244194A1 (en) 2012-09-27
WO2001054675A3 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
NO20054681L (no) Farmasoytiske produkter
CY1120377T1 (el) Στερεη φαρμακευτικη δοσολογικη φαρμακοτεχνικη μορφη που περιεχει λοπιναβιρη
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
UY28348A1 (es) Compuestos novedosos
BR0113669A (pt) Inibidores da desacetilase
NO20042807L (no) Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
ECSP024341A (es) Composiciones farmaceuticas
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
WO2005009381A3 (en) Immediate-release formulation of acid-labile pharmaceutical compositions
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
SE0301700D0 (sv) Novel compounds
HRP20060240T3 (hr) Intranazalni pripravak rotigotina
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
HN2001000262A (es) Kit de repinotano
EA200501697A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
ATE255407T1 (de) Pharmazeutische zusammensetzungen, die terbinafin enthalten
ECSP066291A (es) Sistemas emulsionantes que contienen derivados de azetidina
ATE297760T1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
NO20064808L (no) Orale matrixformuleringer med licarbazepin
BRPI0516464A (pt) formulação farmacêutica, método para a preparação de um produto farmacêutico, e, uso de uma formulação farmacêutica
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
MXPA01011842A (es) Composiciones farmaceuticas para la administracion oral de floroglucinol y preparacion de las mismas.
CY1106964T1 (el) Φαρμακα που περιεχουν ν,ν’-διυποκατεστημενες ενωσεις πιπεραζινης και η χρησιμοποιηση τους
DZ3103A1 (fr) Nouvelles pyrazolo Ä4,3-EÜdiazépines substituées, compositions pharmaceutiques les contenant, utili sation à titre de médicament et procédés pour leurs préparation.